Patients with kidney problems are twice as likely to die from COVID

0
Patients with kidney problems are twice as likely to die from COVID
A patient from Son Espases, is the COVID-19 patient who has spent the most days in an ICU in Spain. image: Twitter

PATIENTS with kidney problems are twice as likely to die from COVID, a new study published by the journal of Anaesthesia  has shown.

The study was led by the Imperial College of London. Doctors conducting the study warned that medics should be on ‘high alert’ for people with kidney complaints and sufferers should be admitted to the ICU much earlier.

-- Advertisement --

Dr Sanooj Soni, who led the study told The Telegraph: “If you end up getting kidney problems on top of severe Covid-19 symptoms your mortality rate doubles right away – that’s a very big deal.”

The study centred on 372 patients admitted to ICU between March and July.

Results of the study showed that 50 per cent of those with pre-existing kidney problems died from the virus, while 21 per cent of patients with no kidney problems succumbed.


“Attention needs to be paid to Covid-19 patients with any form of kidney disease or injury, and every effort made to prevent progression of this disease or injury to reduce mortality in this cohort of patients,” Dr Sami said.

 


________________________________________________________________________

Thank you for taking the time to read this news article “Patients with kidney problems are twice as likely to die from COVID”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.

Euro Weekly News is delighted to continue be able to bring you a range of News from around Spain in English and Global News live as it happens.

Euro Weekly News doesn’t cost you anything but your internet connection. Whether it’s bringing you the local Spanish news or the International news today, we’ve got you covered!

Euro Weekly News, the leading free local and national newspaper in Spain, the people’s paper, we lead others follow!




LEAVE A COMMENT

Please enter your comment!
Please enter your name here